Sabai Global Unifies Services, Streamlining Access to Its Comprehensive IRB and IBC Solutions
Sabai is proud to announce the consolidation of its subsidiary service lines—Castle IRB, CBS IBC and Shield Consulting—under one unified brand: Sabai Global. Now, all Sabai services are accessible through one streamlined platform, offering smoother contracting processes and a single point of contact.
A natural progression in our strategy to expand and enhance client services, this move aligns with Sabai’s commitment to innovative, client-focused solutions and the continued delivery of world-class support in advancing clinical research.
The transformation of our online presence provides a seamlessly efficient environment for our clients to interact with us—delivering on our commitment to provide an elevated service experience from start to finish. Our refreshed visual identity reflects the ethos of partnership and the peace of mind we deliver.
As with the acquisition of Alpha IRB in January 2024, we are accelerating our growth to meet the evolving needs of those we serve while maintaining the personalized, top-tier offerings and deep domain expertise we’re known for.
About Sabai
At Sabai, we deliver relationship-driven, expert service across all of our offerings. We don’t just read you the regulations—we help you truly understand how they impact your clinical development journey.
Sabai IRB Services specializes in providing quality-driven ethical reviews for multi-therapeutic research, supported by our AAHRPP-accredited IRBs. Our Sabai IBC team offers centralized IBC reviews for cell and gene therapy clinical trials, complemented by tailored concierge support for local IBCs. And our expert consultants devise strategic ways to do important work in a cost-effective and sustainable manner.
Whether it’s navigating complex regulations or advancing groundbreaking new therapies, Sabai leads with science and differentiates with service—ensuring the safe and swift progression of your projects.
